Clinical Trials Browser

Phase 2 × Selegiline × Clear all

NCT04586543 2020-10-14

Clinical Trial of Selegiline Plus Docetaxel for the Treatment of Metastatic, Castrate-resistant Prostate Adenocarcinoma

Phase 2 Unknown

Metastatic Castration-resistant Prostate Cancer